B cell depletion in autoimmune rheumatic diseases

被引：21
|
作者：
Pitashny, M
Shoenfeld, Y
机构：
[1] Chaim Sheba Med Ctr, Dept Internal Med B, IL-52621 Tel Hashomer, Israel
[2] Chaim Sheba Med Ctr, Ctr Autoimmune Dis, IL-52621 Tel Hashomer, Israel
[3] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
[4] Tel Aviv Univ, Incumbent Laura Schwarz Kipp Chair Res Autoimmune, IL-69978 Tel Aviv, Israel
来源：
AUTOIMMUNITY REVIEWS | 2005年 / 4卷 / 07期
关键词：
anti-CD20; rituximab; autoimmune diseases; B cell depletion;
D O I：
10.1016/j.autrev.2005.03.002
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Rituximab is a chimeric mouse-human monoclonal antibody, which binds to CD20, a B cell surface marker, leading to cell death by complement induced lysis and apoptosis. Since the introduction of this drug in the treatment of non-Hodgkin lymphoma, its applications have been extended to autoimmune diseases. This review summarizes the actual possible uses of this novel immune system targeted drug, and explains the mechanism of B cell depletion in autoimmune diseases. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码：436 / 441
页数：6
相关论文
共 50 条
  • [1] B cell checkpoints in autoimmune rheumatic diseases
    Rubin, Samuel J. S.
    Bloom, Michelle S.
    Robinson, William H.
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2019, 15 (05) : 303 - 315
  • [2] B cell checkpoints in autoimmune rheumatic diseases
    Samuel J. S. Rubin
    Michelle S. Bloom
    William H. Robinson
    [J]. Nature Reviews Rheumatology, 2019, 15 : 303 - 315
  • [3] B cell depletion therapy in autoimmune diseases
    Sanz, Inaki
    Anolik, Jennifer H.
    Looney, R. John
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 : 2546 - 2567
  • [4] B-cell depletion in autoimmune diseases
    Schett, Georg
    Mielenz, Dirk
    Nagy, Gyorgy
    Kronke, Gerhard
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2024,
  • [5] Alterations in B Cell Subsets and BAFF Levels in Autoimmune Rheumatic Diseases Treated with B Cell Depletion Therapy: Rituximab
    Lutalo, Pamela M. K.
    D'Cruz, David P.
    Spencer, Jo
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1178 - S1179
  • [6] ALTERATIONS IN B CELL SUBSETS AND BAFF LEVELS IN AUTOIMMUNE RHEUMATIC DISEASES TREATED WITH B CELL DEPLETION THERAPY RITUXIMAB
    Lutalo, Pamela M. K.
    D'Cruz, David
    Spencer, Jo
    [J]. RHEUMATOLOGY, 2015, 54 : 163 - 163
  • [7] B cell depletion for autoimmune diseases in paediatric patients
    Jansson, Annette F.
    Sengler, Claudia
    Kuemmerle-Deschner, Jasmin
    Gruhn, Bernd
    Kranz, A. Birgitta
    Lehmann, Hartwig
    Kleinert, Daniela
    Pape, Lars
    Girschick, Hermann J.
    Foeldvari, Ivan
    Haffner, Dieter
    Haas, Johannes P.
    Moebius, Dagmar
    Foell, Dirk
    Peitz, Joachim
    Grote, Veit
    [J]. CLINICAL RHEUMATOLOGY, 2011, 30 (01) : 87 - 97
  • [8] B-Cell Depletion and Repopulation in Autoimmune Diseases
    Jacques-Olivier Pers
    Capucine Daridon
    Boutahar Bendaoud
    Valérie Devauchelle
    Christian Berthou
    Alain Saraux
    Pierre Youinou
    [J]. Clinical Reviews in Allergy & Immunology, 2008, 34 : 50 - 55
  • [9] B-Cell depletion and repopulation in autoimmune diseases
    Pers, Jacques-Olivier
    Daridon, Capucine
    Bendaoud, Boutahar
    Devauchelle, Valerie
    Berthou, Christian
    Saraux, Alain
    Youinou, Pierre
    [J]. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2008, 34 (01) : 50 - 55
  • [10] B cell depletion for autoimmune diseases in paediatric patients
    Annette F. Jansson
    Claudia Sengler
    Jasmin Kuemmerle-Deschner
    Bernd Gruhn
    A. Birgitta Kranz
    Hartwig Lehmann
    Daniela Kleinert
    Lars Pape
    Hermann J. Girschick
    Ivan Foeldvari
    Dieter Haffner
    Johannes P. Haas
    Dagmar Moebius
    Dirk Foell
    Joachim Peitz
    Veit Grote
    [J]. Clinical Rheumatology, 2011, 30 : 87 - 97
12345